R+D at the service of the textile industry, creating and transferring value.
Added-value solutions for growing strategic markets. AITEX is focusing its research on the following areas:
- Textile-based functional products for Health, Sports and Personal Protection.
- Textiles to protect and provide solutions for the natural world and society.
- Textile solutions for construction and habitat; energy efficiency and smart interior design.
- Textile solutions for transport systems; lighter, cleaner and safer
- Custom-made functional fashion articles
AITEX is working on the research and development of the following projects:
The main objective of year two of DENTALTEX II is to create a prototype consisting of a micro-porous central core, covered by different nanofibre veils additivated with drugs for periodontal treatment.
[+] for more information onDENTALTEX II
The main objective of the FUNDETEX project is to develop detergent and softener formulations that provide functional properties to the skin that are beneficial for the user’s health, through research into additives and liquid and solid functional compounds of interest (mosquito-repellent, moisturising, anti-cellulite, etc.). In addition, studies will determine how effective the transfer of the properties of the detergent or softener to the user is, when in contact with the washed clothes and fabrics.
[+] for more information on FUNDETEX
The core objective of BIENESMART is the development of textile solutions that monitor vital signs and physiological and biological parameters for the improvement of people’s well-being.
[+] for more information on BIENESMART
The objective of the STAR project is the research and development of smart textiles for architecture and construction that allow users to interact with technological, sustainable and creative infrastructures that enhance their quality of life.
[+] for more information on STAR
These projects are funded by the Conselleria d’Economia Sostenible, Sectors Productius, Comerç i Treball of the Generalitat Valenciana, through IVACE.